PEDIATRICS Vol. 6 No. 2 August 1950, pp. 173-182
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VAUGHAN, V. C.
Right arrow Articles by DIAMOND, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VAUGHAN, V. C., III
Right arrow Articles by DIAMOND, L. K.

ERYTHROBLASTOSIS FETALIS

I. Problems in the Interpretation of Changing Mortality in Erythroblastosis Fetalis

VICTOR C. VAUGHAN III M.D.1, FRED H. ALLEN JR. M.D.1, and LOUIS K. DIAMOND M.D.1

1 The Department of Pediatrics, Harvard Medical School, the Children's Medical Center, the Boston Lying-in Hospital, and the Blood Grouping Laboratory, Boston.

1. Twelve years' experience with 539 cases of erythroblastosis fetalis has been reviewed.

2. It is not possible to show beyond the statistical limits of chance that any change in mortality of erythroblastosis fetalis in relation to therapy in live born infants has occurred in this time.

3. It is probable that the early induction of labor has caused an increased risk to live born babies during part of this period, when erythroblastosis fetalis has been complicated by immaturity, particularly before 38 weeks' gestation.

4. Caution is urged in assaying the value of any therapeutic measure, the use of which in erythroblastosis fetalis may result in a selected body of clinical material.

Submitted on December 4, 1949